CardieX & Invaryant enable clinical trials with advanced new AI medical technology

Australia's CardieX Limited, a global health technology company focused on patient-centric healthcare research and impro...

January 5, 2023 | Thursday | News
Australia rolls out new policy to make medicines cheaper

Millions of Australians will pay up to 29 per cent less for their Pharmaceutical Benefits Scheme (PBS) prescriptions, wi...

January 4, 2023 | Wednesday | News
Australia raises concerns over lack of research funding for treating oral disorders

Major government research funding schemes aren’t keeping up with the burden of oral diseases, according to a new s...

December 23, 2022 | Friday | News
Australian first research trial to explore use of psychedelics for alcohol use disorder

Researchers at the University of Sydney are embarking on an Australian first research trial into the use of psychedeli...

December 22, 2022 | Thursday | News
Researchers at Australia & Korea investigate effect of COVID-19 virus on vision

A study, co-led by Australia-based Griffith University’s Menzies Health Institute and South Korea’s Center f...

December 20, 2022 | Tuesday | News
Researchers identify ‘born to be bad’ colorectal cancer tumours

An international research team has identified ‘born to be bad’ colorectal tumours in people with early stage...

December 19, 2022 | Monday | News
Australia-based Bionomics appoints new President and Chief Executive Officer

Australia's Bionomics has appointed Spyridon “Spyros” Papapetropoulos, M.D. as President and Chief Exec...

December 15, 2022 | Thursday | News
Australia invests $264 M in 258 novel health and medicine research projects

The Australian Government has announced $264 million in funding to support 258 exceptional health and medical resear...

December 16, 2022 | Friday | News
Australia announces new funding arrangement for surgical consumables

Australia has announced a new funding arrangement for around 500 surgical general use and consumable items for use by pr...

December 14, 2022 | Wednesday | News
Australian pharma major CSL announces next CEO & Managing Director

The Board of Directors of CSL Limited has appointed Dr Paul McKenzie as Chief Executive Officer (CEO) and Managing Direc...

December 13, 2022 | Tuesday | News
Trial of ultrasound treatment for Alzheimer’s underway in Australia

A pioneering treatment for Alzheimer’s disease, developed at The University of Queensland (UQ) in Australia, is be...

December 13, 2022 | Tuesday | News
Australia launches national COVID-19 health management plan for 2023

The Australian government has launched the National COVID-19 Health Management Plan for 2023. The National Plan reflects...

December 12, 2022 | Monday | News
Australia provides funding to QUT training programme to accelerate medtech innovations

The BridgeTech Programme, a successful medtech commercialisation training programme delivered by Queensland Unive...

December 9, 2022 | Friday | News
CSL invests $900 M in new Australian plasma fractionation facility

CSL has unveiled the future of plasma manufacturing in Australia with the opening of their $900 million Plasma Fractiona...

December 9, 2022 | Friday | News
Alliance Pharma unveils state-of-the-art bioanalytical laboratory in Brisbane

Alliance Pharma, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and bioph...

December 8, 2022 | Thursday | News
Australian startup Tessara Therapeutics partners with NETRI to design organ-on-chip models

Australia-based startup Tessara Therapeutics and French firm NETRI have established a collaboration to develop a family ...

December 7, 2022 | Wednesday | News
Australia's Griffith University joins $280 M partnership to deliver mRNA vaccine outcomes

Queensland will become a global mRNA vaccine hub with leading healthcare company Sanofi partnering with Griffith Univers...

December 7, 2022 | Wednesday | News
Vaxxas raises A$34 M to clinically advance needle-free vaccines

Vaxxas has completed a financing round which raised $23 million (A$34 million) in new funds. This investment round was l...

December 6, 2022 | Tuesday | News